Astrazeneca/ Treatment Patterns, Outcomes, And Patient-Reported Health-Related Quality Of Life: A Prospective Disease Registry Of Patients With Mantle Cell Lymphoma Treated With Novel Agents Read more
An Open-Label, Multicenter, Phase I Trial Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of BTCT4465A In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin?S Lymphoma And Chronic Lymphocytic Leukemia Read more
A Phase 2 Multicenter Study Evaluating The Efficacy Of KTE-C19 In Subjects With Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Read more
Extended Treatment Protocol For Subjects Continuing To Benefit From Ibrutinib After Completion Of Ibrutinib Clinical Trials Read more
A Phase 1, Multicenter, Open-Label Study Of CC-97540, CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, In Subjects With Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma Read more
